Skip to main content

Remote Job Finders (RJF)

Amgen shores up Tavneos’ FDA defense with Duke data analysis

After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.

Novo hit with cybersecurity breach, urges vigilance among trial participants

Novo Nordisk said that the information affected by the breach shouldn’t allow third parties to “identify participants in our clinical trials” despite “unauthorized access” to patients’ personal data.

May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech

For the second time in 2026, the number of biopharma professionals affected by made or projected workforce reductions rose year over year. In May, layoffs spiked nearly 50%, mainly due to Takeda and BioNTech axing a combined 6,360 employees.

The wait continues: pressure to operate lean among factors behind slow job market

Just 23% of respondents to a BioSpace LinkedIn poll expect the biopharma job market will rebound in 2026. Three experts discuss when they see a turnaround happening and how increasing emphasis on cost efficiency is impacting hiring practices.
Scroll to top